Prognosis of Breast Cancer with Bone Metastasis Studied by Modes of Recurrencedoi:10.3919/JJSA.77.2881Mayuko MatsumuraFuyou KimuraHiroshi KaiseKimito YamadaTakashi IshikawaNorio Kouno
11 To our knowledge, all studies evaluating luminal/basal subtypes within prostate cancer have been limited to primary prostate cancer tissue, in part due to the difficulties in obtaining biopsies from metastases, which are often confined to bone. Metastatic castration-resistant prostate cancer (mCRPC...
Cancer Prognosis for early-stage cancer is primarily based on tumor type, disease burden, and aggressiveness suggested by clinical, imaging, laboratory, pathologic, and molecular characteristics. For more advanced cancers, functional status has consistently demonstrated an association with survival, although...
Virtually all successful treatments of cancer either create, restore or enhance the antitumour immune response. Therefore, the specific features of the immune microenvironment, both before and after treatment, are important determinants of patients' outc
Moreover, HS6ST2 is positively or negatively associated with prognosis in different cancers. HS6ST2 expression was not only associated with MSI in 5 cancer types and associated with TMB in 10 cancer types, and it's significantly correlated with DNA methylation in 13 types of cancer, but it'...
Approximately 70% of patients with advanced breast cancer develop bone metastases, accompanied by complications, such as bone pain, fracture, and hypercalcemia. However, our understanding of the molecular mechanisms that govern this process remains fragmentary. Osterix (Osx) is a zinc finger-containing...
5 There have been several reports of PD-L1-high expression groups being correlated with worse prognosis in pancreatic cancer.6 Immune checkpoint inhibitors (ICIs) that activate autoimmunity have shown effective results in lung cancer.7,8 They are expected to be effective in pancreatic cancer as ...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th
Prostate cancer (PCa) is the leading cause of cancer-related death among men worldwide. Knowledge of the prognostic factors of PCa and the bone metastasis pattern of patients would be helpful for patients and doctors. The data of 177,255 patients with pr
and metastatic cancerous cells to use resultants for designing new therapeutic agents which are able to target both primary and metastatic breast tumor cells. In this study, the gene expression dataset with accession number GSE55715 was analyzed containing two primary tumor samples, three bone-metasta...